Objectives-To analyse the glycosaminoglycans of the adult human rotator cuff tendon matrix, to characterise changes in the glycosaminoglycan composition with age and in chronic rotator cuff tendinitis. Methods-Rotator cuff (supraspinatus) tendons (n = 84) and common biceps tendons (n = 26) were obtained from cadavers with no history of tendon pathology (age range 11-95 years). Biopsies of rotator cuff tendons (supraspinatus and subscapularis tendons, n = 53) were Conclusions-The normal supraspinatus tendon has the proteoglycan/glycosaminoglycan of tendon fibrocartilage, which it is suggested is an adaptation to mechanical forces (tension, compression and shear) which act on the rotator cuff tendons in the shoulder, although other factors such as reduced vascularity, low oxygen tension and the influence of local growth factors may also be important. This functional adaptation may have important consequences for the structural strength of the supraspinatus tendon and to influence the ability of the tendon to repair after injury. The glycosaminoglycan composition of tendon specimens from patients with chronic tendinitis is consistent with acute inflammation and new matrix proteoglycan synthesis, even in relatively old tendon specimens and after at least one injection of corticosteroid. (Ann Rheum Dis 1994; 53: 367-376) Chronic shoulder pain is a common and disabling condition that is often seen in rheumatological practice and prevalent in the elderly community.1 1 Relatively little is known about the underlying pathology, as surgical biopsies of human tendons are rarely obtained and are not required for diagnosis. The main causes of shoulder pain are lesions of the rotator cuff tendons, most commonly the supraspinatus tendon, although the subscapularis, infraspinatus and teres minor 367 group.bmj.com on June 25, 2017 -Published by http://ard.bmj.com/ Downloaded from Riley, Harrall, Constant, Chard, Cawston, Hazleman tendons may also be involved.3 The clinical description of 'tendinitis' is often used to describe painful tendon lesions, although there is little evidence for an acute inflammatory process in degenerate and spontaneously ruptured tendons. Rotator cuff tendinitis does not necessarily resolve with time and is often refractory to conservative therapies, including rest, physiotherapy and local corticosteroid injections.4 5
hyaluronan in these tendons [9.3 (2.8) ,ug/mg dry weight and 10-8 (4.3) ,Ig/mg dry weight respectively] and there was no significant change ofhyaluronan with age. Keratan sulphate was a small but significant component of the supraspinatus tendon [0 43 (0.33) jig/mg dry weight, n = 25], whereas there was little or none in the common biceps tendon [0-04 (0.05) ,ug/mg dry weight, n = 8] and there was no significant change across the age range. In the supraspinatus tendon, there was a significant decrease in total glycosaminoglycan, chondroitin sulphate and dermatan sulphate with age (p < 0.001), whether expressed relative to the tendon dry weight or total collagen content, and no change in the relative proportion of the different GAG types. There was, however, a large degree of variation within the samples. Supraspinatus tendons from patients with chronic tendinitis had a significantly increased concentration of hyaluronan [30.4 (10.1) ,ug/mg dry weight, p < 0.001], chondroitin sulphate [8.4 (1) (2) (3) (4) (5) (6) (7) (8) ,ug/mg dry weight, p < 0.05] and dermatan sulphate [3.8 (1.1) ,ug/mg dry weight, p < 0-001] compared with normal cadaver supraspinatus tendons, although the keratan sulphate content was not significantly different [0.18 (0.05) ,ug/mg dry weight]. Conclusions-The normal supraspinatus tendon has the proteoglycan/glycosaminoglycan of tendon fibrocartilage, which it is suggested is an adaptation to mechanical forces (tension, compression and shear) which act on the rotator cuff tendons in the shoulder, although other factors such as reduced vascularity, low oxygen tension and the influence of local growth factors may also be important. This functional adaptation may have important consequences for the structural strength of the supraspinatus tendon and to influence the ability of the tendon to repair after injury. The glycosaminoglycan composition of tendon specimens from patients with chronic tendinitis is consistent with acute inflammation and new matrix proteoglycan synthesis, even in relatively old tendon specimens and after at least one injection of corticosteroid. Chronic shoulder pain is a common and disabling condition that is often seen in rheumatological practice and prevalent in the elderly community.1 1 Relatively little is known about the underlying pathology, as surgical biopsies of human tendons are rarely obtained and are not required for diagnosis. The main causes of shoulder pain are lesions of the rotator cuff tendons, most commonly the supraspinatus tendon, although the subscapularis, infraspinatus and teres minor tendons may also be involved. 3 The clinical description of 'tendinitis' is often used to describe painful tendon lesions, although there is little evidence for an acute inflammatory process in degenerate and spontaneously ruptured tendons. Rotator cuff tendinitis does not necessarily resolve with time and is often refractory to conservative therapies, including rest, physiotherapy and local corticosteroid injections. 4 5 Degeneration of the tendon matrix is generally considered to predispose to 'tendinitis' and eventual rupture, as normal tendons are immensely strong under tension. 6 A variety of factors including ageing, vascular insufficiency, the anatomical shape of the acromium, impingement against osteophytes, and repetitive activities have all been implicated in the pathology of rotator cuff tendinitis. 7 8 Whatever the cause, the most frequent site of all tendon lesions is the 'critical zone' in the supraspinatus tendon, approximately one centimetre from the bone insertion and a region of blood vessel anastomoses. 9 Although they form a minor proportion of the extracellular matrix, proteoglycans and their constituent glycosaminoglycans can influence many important physiological processes, such as ion transport, the diffusion of nutrients and water retention.1" They are also involved in specific interactions that can influence important processes such as collagen fibrillogenesis, cell-cell interactions, growth factor binding and cell regulation." 12 Tendons have previously been considered to be relatively inert and homogenous structures, although there are regional differences within tendons and differences in structure and composition between different tendons.'3 In particular, changes in the glycosaminoglycan and proteoglycan composition have been described during maturation and ageing," after immobilisation and exercise'5 in response to mechanical forces'6 and after tendon injury. 17 A large histopathological study of 865 spontaneously ruptured human tendons (not including rotator cuff tendons), described an accumulation of glycosaminoglycans between the collagen fibres in 2 1/% of tendons.'8 These degenerative changes were second in frequency only to cell changes ascribed to tissue hypoxia, which were found in 44% of tendons. Interstitial glycosaminoglycan accumulation was also observed in 9% (42/445) of non-ruptured tendons. In a recent histological study of macroscopically normal cadaver supraspinatus tendons, we showed that glycosaminoglycan accumulation was the most common abnormality, found in 18% of non-ruptured specimens but only in specimens over the age of thirty years. '9 We hypothesised that quantitative and qualitative changes in the matrix glycosaminoglycan and proteoglycan composition may be found in ageing and degenerate tendons and may predispose to chronic rotator cuff tendinitis.
We investigated whether the ageing supraspinatus tendon is capable of maintaining the normal proteoglycan matrix and compared the glycosaminoglycan composition with a sample of common biceps tendons, a flexor tendon that is rarely involved in any pathology and likely to show changes due to ageing alone. We also obtained a relatively large number of surgical specimens of rotator cuff tendons from patients undergoing shoulder surgery for chronic tendinitis (a rotator cuff tear) and other painful shoulder conditions, to investigate the changes in glycosaminoglycans associated with rotator cuff tendinitis and human tendon pathology.
Methods

TENDON COLLECTION
Specimens of supraspinatus tendons and common biceps tendons were collected from cadavers at necropsy. None of the subjects had any known history of tendinitis or shoulder pathology. Shoulders with gross rotator cuff lesions were excluded from the study. Surgical biopsies of rotator cuff tendons (supraspinatus and subcapularis tendon) were collected by CRC. Tendon tissue was taken only when ethically justified, in order to bring together less damaged tissue to enhance the prospects of successful repair of sutured material. Patients with chronic 'tendinitis' (a rotator cuff tear) had been treated conservatively with at least one corticosteroid injection before surgery. Tendons with 'calcifying tendinitis' had radiographically detectable mineral deposits-tissue was excised from around the deposit. Biopsies of tendons were also taken during fracture repairs, prosthetic shoulder replacement and 'stabilisation' operations to prevent recurrent dislocation. Figure 1 Cellulose acetate electrophoresis ofglycosaminoglycans. Cadaver tendon specimens were digested with papain and the crude digest was subjected to electrophoresis at 45 mA for one hour in 0 3 M calcium acetate buffer pH 7-2 and stained with 0-2% Alcian Blue 8GX in 0 3% acetic acid 0-05 M MgCl2. Glycosaminoglycan standards (1 0 mg/ml each) of chondroitin-4-sulphate (C4S), chondroitin-6-sulphate (C6S), dermatan sulphate (DS) and hyaluronan (HA) were obtainedfrom Sigma. Some samples were digested with chondroitinase enzymes forfour hours at 37°C. O = origin. ABC = chondroitinase ABC digest. AC = chondroitinase AC. C = undigested control. Lanes 1 and 2, C4S; lanes 3 and 4, DS; Lanes 5 and 6, C6S; lanes 7 and 8, HA; lanes 9 to 11, 12 year old supraspinatus and lanes 12 to 14, 19year old supraspinatus. Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis (fig 2) , although the relative proportion (CS/ DS) did not change (data not shown).
There was no significant difference between males and females, left and right shoulders and bilateral tendon specimens (data not shown).
The same trends were observed when the data was expressed relative to the collagen content of the tendon (data not shown). There were, however, significant differences between the bone and muscle ends of the tendon (table 3) .
There was a greater concentration of GAG at the bone end of the tendon, the majority of which was chondroitin sulphate.
A proportion of the sulphated GAG extracted from the supraspinatus tendon was resistant to chondroitinase ABC, even after extended periods of digestion of up to five days (data not shown). However, after digestion with keratanase for 18 hours at 37°C, only a small proportion (up to 40%) of the dimethylmethylene blue dye-binding activity was eliminated. Consequently it was not safe to assume that all the glycosaminoglycan resistant to chondroitinase ABC was keratan sulphate (see KS ELISA data below).
The hyaluronan content was calculated from the uronic acid and GAG data, assuming that human tendon glycosaminoglycans contain the same proportion of uronic acid as animal glycosaminoglycans, as reported by Greiling.23 The mean (SD) hyaluronan content was 9 3 (2 8) pug/mg dry weight and there was no change with increasing specimen age (data not shown). The common biceps tendons contained significantly less total GAG and uronic acid compared to the supraspinatus tendon (p < 0 001). In addition, the major sulphated glycosaminoglycan was dermatan sulphate, which comprised almost 75% ofthe total GAG (fig 4) .
There was no significant change in the total GAG content of the biceps tendon with increasing specimen age and no change in the relative proportion of chondroitin sulphate and dermatan sulphate (data not shown). Although the total uronic acid content was significantly lower, the mean (SD) hyaluronan content was calculated to be 10-8 (4 3) ,ug/mg dry weight, which was not significantly different from the normal supraspinatus tendon (fig 5) . There was no significant change in hyaluronan with increasing specimen age, similar to the normal supraspinatus tendon sample (data not shown).
SUPRASPINATUS TENDONS FROM PATIENTS WITH CHRONIC ROTATOR CUFF TENDINITIS
The total GAG content of biopsy specimens from supraspinatus tendinitis was not significantly different from normal cadaver supraspinatus tendons. However, there was a significant increase in uronic acid (p < 0 00 1), chondroitin sulphate (p < 0 05) and dermatan sulphate ( Specimens of tendon from patients with calcifying tendinitis and from fracture repair operations were not significantly different from normal cadaver tendons, although there were few specimens and considerable variation within the samples.
SUBSCAPULARIS TENDONS FROM SHOULDER OPERATIONS
There were similarities between subscapularis tendons from patients with chronic tendinitis and the biopsy specimens of supraspinatus tendinitis. Although there was no significant difference in total GAG, there was a significant increase in both the uronic acid and dermatan sulphate content (p<0 01 and p<0 001 respectively). The chondroitin sulphate content, however, was significantly lower than that found in the normal supraspinatus tendon tendinitis replacement Figure 7 Glycosaminoglycans ofbiopsy specimens ofsubscapularis tendon. Total sulphated glycosaminoglycan (GAG), uronic acid (UA), chondroitin sulphate (CS) and dermatan sulphate (DS) were assayed as described. Data shown for eight specimens from patients with chronic tendinitis (age range 68-80, mean 73-4), four specimensfrom stabilisation operations (age range 19-31, mean 25 2) and seven specimensfrom shoulder replacement operations (age range 40-76, mean 57-3) and compared with 60 macroscopically normal cadaver supraspinatus tendons (age range 11-95, mean 58 1). Dotted lines represent the mean (2 SD). * = p < 0 05, ** = p < 0 01, ***p < 0-001.
(p < 0.00 1), although significantly greater (on average) than that found in the other subscapularis tendon biopsy specimens (fig 7) .
Specimens from stabilisation operations and shoulder replacement operations had a similar GAG composition to the common biceps tendon, with a small quantity of predominantly dermatan sulphate proteoglycans and a very low chondroitin sulphate content. However these specimens are not necessarily representative of normal subscapularis tendons, as they are likely to have been subject to some abnormal stresses and/or pathology before the shoulder operation. Normal cadaver subscapularis tendons were not obtained. 
KERATAN SULPHATE ANALYSIS
The presence of keratan sulphate in the supraspinatus tendon matrix was confirmed by ELISA using the 5D4 monoclonal antibody (table 4) . There was no significant change in keratan sulphate content with age, although there was a large degree of variation in the sample. In addition, there was no significant difference in the diseased specimens of supraspinatus tendon, although a small number of specimens were analysed. In contrast, very little or no keratan sulphate was detected in specimens of normal common biceps tendon. However, it is acknowledged that the ELISA technique may underestimate the true keratan sulphate content of the tendons, as the assay is specific for a single epitope, which might be hidden or only selectively expressed in some forms of keratan sulphate. and there was no significant difference in the proteoglycan solubility between the different tendon samples (data not shown). The proteoglycans were taken up in SDS sample buffer and analysed by reducing 4-15% gradient SDS-PAGE. Three species of proteoglycan were seen in supraspinatus tendons from across the age range (fig 8) . Two diffuse and lightly stained bands, with relative molecular weights of approximately 100 kD (range 80-130 kD) and 220 kD, were tentatively identified as the small proteoglycans decorin and biglycan respectively, on the basis of previously published data.27 The proteoglycan at the gel interface, excluded by its size from entering the polyacrylamide matrix, was probably a large proteoglycan such as aggrecan, which has been identified by similar methods in some animal tendons and more recently in the human tibialis anterior tendon.28 A large number of proteins were present in each of the tendon extracts (fig 7b) , although no qualitative difference was observed with age.
Discussion
The vulnerability of the rotator cuff tendons to degeneration and rupture has been ascribed to a number of factors, including a reduction in vascularity, age related changes of the tendon matrix and mechanical trauma. Although there have been a number of histopathological studies describing degenerative changes in tendons, including an abnormal accumulation of glycosaminoglycans, there have been few chemical studies of human tendon proteoglycans, in particular of the rotator cuff tendons and their changes with age and in disease. An earlier study of the supraspinatus tendon described histological evidence of chemical degradation of both collagen and glycosaminoglycans with increasing age.29
Brewer's study, however, was of just three cadaver tendons and cannot be presumed to be illustrative of the ageing process. This study is the first major qualitative and quantitative study of the glycosaminoglycans of the adult human supraspinatus tendon matrix, from a relatively large sample of both cadaver and patient specimens. The maintenance of the tendon matrix is an important function of the tenocytes and has important consequences for the ability of the tissue to resist mechanical forces and to repair in response to tendon injury. A reduced vascular perfusion in the 'critical zone' of the supraspinatus tendon may be in part responsible for this reduction in proteoglycan synthetic activity, although it is also possible that senescence of the cell population is a significant factor. In this respect it is interesting that the proliferative activity of adult human tenocytes is not significantly affected by age.31
It is possible that the tenocytes are less synthetically active and consequently their ability to maintain the tendon matrix may be significantly reduced. Future studies of tenocytes isolated from ageing adult supraspinatus tendons are required to address this question.
WHAT FACTI ORS INFLUENCE SUPRASPINATUS TENDON GLYCOSAMINOGLYCAN COMPOSITION?
There was a large degree of variation in the sample, with some older tendons containing as much glycosaminoglycan as younger tendons, which suggests that factors other than age have an influence on the glycosaminoglycan content of the tendon. For example, the glycosaminoglycan composition may be closely linked to the levels of physical activity of an individual, as it has been shown that immobilisation causes a reduction in glycosaminoglycan content and exercise can reverse the agerelated decline in glycosaminoglycan content of the rat patellar tendon. ' 36 will have important consequences for the mechanical strength of the supraspinatus tendon, resulting in a reduced capacity to resist tensional forces. As yet there have been no studies demonstrating a difference in the tensile properties of fibrocartilage in animal tendons. In addition, the fibrocartilaginous composition may also have important consequences for the wound healing potential of the tendon. In animal tendons, these regions are relatively avascular and levels of DNA synthesis are lower compared to adjacent tension bearing regions.37 An avascular 'critical zone' is also proposed in the supraspinatus tendon and in theory these regions have a reduced capacity to repair. However, the fibrocartilaginous region of the canine flexor digitorum profundus tendon demonstrated a more rapid return of strength after injury than the adjacent tension bearing region. 38 The difference in response may be related to the specific magnitude and/or orientation (compression, shear or tension) of the mechanical forces acting on the respective repair sites. The relevance of these studies to adult human supraspinatus tendons is open to question and future studies are required to examine the repair response in ageing human tendons at different anatomical sites.
It has been previously proposed that 'fibrocartilaginous transformation' is a degenerative event which may pre-dispose the tendon to rupture. '9 This study has shown that the biochemical profile of tendon fibrocartilage is a normal feature of the supraspinatus tendon, which is more pronounced at the bone end compared with the muscle end of the tendon. The anatomical disposition of the supraspinatus suggests that for part of its length, in particular towards the bone insertion, the tendon is compressed against the head of the humerus below or squeezed against the acromium and/or coraco-humeral ligament above, particularly when the arm is elevated. The subscapularis tendon is less often affected by 'tendinitis' than the supraspinatus tendon and it may be significant that subscapularis tendons not affected by tendinitis were similar in composition to a normal flexor tendon which experiences predominantly tensional forces. It is possible that the subscapularis tendon, which is located in the anterior region of the rotator cuff complex, does not normally experience significant compressive and/or shear forces. In contrast, subscapularis specimens from patients with chronic tendinitis had a significantly higher concentration of chondroitin sulphate. This may be caused by an altered pattern of mechanical forces on the tendon before rupture. Impingement of the supraspinatus may be a principal cause of rotator cuff tears8 and it might be expected that the tendons of certain individuals may be disposed to a greater degree of compression than other specimens. This may be due to either the anatomical shape and slope of the acromium or to particular repetitive and/or overhead activities related to certain sports and occupations. Consequently, the interaction of functional requirements, extrinsic mechanical factors and anatomical variation may affect the intrinsic cell matrix response of the tenocytes in the rotator cuff tendons in the shoulder.
INFLAMMATION AND REPAIR IN DEGENERATIVE 'TENDINITIS
This study has also shown that the degeneration of tendons affected by chronic tendinitis is not accompanied by a decrease in the glycosaminoglycan content, as described in other pathological situations, such as, articular cartilage fibrillation and osteoarthritis. 39 In contrast, the principal changes are a substantial increase in hyaluronan accompanied by an increase in dermatan sulphate and, to a lesser degree, of chondroitin sulphate. These changes are consistent with the inflammatory phase of wound healing, with new matrix synthesis produced in response to acute tendon injury. 
